These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30706779)

  • 1. Proteasome Inhibitors in Cancer Therapy and their Relation to Redox Regulation.
    Sari G; Okat Z; Sahin A; Karademir B
    Curr Pharm Des; 2018; 24(44):5252-5267. PubMed ID: 30706779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox-regulated pathway of tyrosine phosphorylation underlies NF-κB induction by an atypical pathway independent of the 26S proteasome.
    Cullen S; Ponnappan S; Ponnappan U
    Biomolecules; 2015 Feb; 5(1):95-112. PubMed ID: 25671697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasome and cancer.
    Catalgol B
    Prog Mol Biol Transl Sci; 2012; 109():277-93. PubMed ID: 22727425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteasome inhibitors in cancer therapy: Treatment regimen and peripheral neuropathy as a side effect.
    Kaplan GS; Torcun CC; Grune T; Ozer NK; Karademir B
    Free Radic Biol Med; 2017 Feb; 103():1-13. PubMed ID: 27940347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Small Molecules Targeting Ubiquitin-Proteasome System for Cancer Therapy.
    Ao N; Chen Q; Liu G
    Comb Chem High Throughput Screen; 2017; 20(5):403-413. PubMed ID: 28699494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasome inhibitors with photocontrolled activity.
    Hansen MJ; Velema WA; de Bruin G; Overkleeft HS; Szymanski W; Feringa BL
    Chembiochem; 2014 Sep; 15(14):2053-7. PubMed ID: 25125335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proteasome inhibition as a new strategy in cancer therapy and chemoprevention].
    Maliński M; Cichocki M
    Postepy Hig Med Dosw (Online); 2013 Feb; 67():90-106. PubMed ID: 23475486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting proteasomes with natural occurring compounds in cancer treatment.
    Cecarini V; Cuccioloni M; Mozzicafreddo M; Bonfili L; Angeletti M; Eleuteri AM
    Curr Cancer Drug Targets; 2011 Mar; 11(3):307-24. PubMed ID: 21265733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cadmium pyrithione suppresses tumor growth in vitro and in vivo through inhibition of proteasomal deubiquitinase.
    Chen X; Wu J; Yang Q; Zhang X; Zhang P; Liao S; He Z; Wang X; Zhao C; Liu J
    Biometals; 2018 Feb; 31(1):29-43. PubMed ID: 29098502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clogging the Ubiquitin-Proteasome Machinery with Marine Natural Products: Last Decade Update.
    Della Sala G; Agriesti F; Mazzoccoli C; Tataranni T; Costantino V; Piccoli C
    Mar Drugs; 2018 Nov; 16(12):. PubMed ID: 30486251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting heat shock proteins 70/90 and proteasome for cancer therapy.
    Wang RE
    Curr Med Chem; 2011; 18(27):4250-64. PubMed ID: 21838681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Search for Inhibitors of the Ubiquitin-Proteasome System from Natural Sources for Cancer Therapy.
    Tsukamoto S
    Chem Pharm Bull (Tokyo); 2016; 64(2):112-8. PubMed ID: 26833439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting proteasomal pathways by dietary curcumin for cancer prevention and treatment.
    Hasima N; Aggarwal BB
    Curr Med Chem; 2014; 21(14):1583-94. PubMed ID: 23834173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of ubiquitin proteasome pathway in cancer development.
    Yerlikaya A; Yöntem M
    Recent Pat Anticancer Drug Discov; 2013 Sep; 8(3):298-309. PubMed ID: 23061719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel nickel complex works as a proteasomal deubiquitinase inhibitor for cancer therapy.
    Zhao C; Chen X; Zang D; Lan X; Liao S; Yang C; Zhang P; Wu J; Li X; Liu N; Liao Y; Huang H; Shi X; Jiang L; Liu X; He Z; Dou QP; Wang X; Liu J
    Oncogene; 2016 Nov; 35(45):5916-5927. PubMed ID: 27086925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteasome inhibitors induce AMPK activation via CaMKKβ in human breast cancer cells.
    Deshmukh RR; Dou QP
    Breast Cancer Res Treat; 2015 Aug; 153(1):79-88. PubMed ID: 26227473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the ubiquitin-proteasome system for cancer treatment: discovering novel inhibitors from nature and drug repurposing.
    Soave CL; Guerin T; Liu J; Dou QP
    Cancer Metastasis Rev; 2017 Dec; 36(4):717-736. PubMed ID: 29047025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the ubiquitin proteasome system in lymphoma.
    Suh KS; Tanaka T; Sarojini S; Nightingale G; Gharbaran R; Pecora A; Goy A
    Crit Rev Oncol Hematol; 2013 Sep; 87(3):306-22. PubMed ID: 23541070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular Responses to Proteasome Inhibition: Molecular Mechanisms and Beyond.
    Albornoz N; Bustamante H; Soza A; Burgos P
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin as a proteasome inhibitor. Is there any clinical evidence?
    Vriend J; Reiter RJ
    Life Sci; 2014 Oct; 115(1-2):8-14. PubMed ID: 25219883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.